In vitro studies demonstrated that TNFα (a common inflammatory cytokine) activates the transcription factor NF-κB and decreases the levels of ZO-1 in RPE cell lines; in vivo, pharmacological inhibition of this pathway rescues the integrity of tight junction complexes in a mouse model of diabetic retinopathy [46]. Here, NFKB1 is linked to diabetic retinopathy.